Study of three different methods of hepatic blood inflow occlusion in patients undergoing hepatectomy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001483

Enrollment

Unknown

Registered

2011-08-17

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

A:Occlusion of hepatoduodenal ligament

B:Occlusion of portal vein

C:Occlusion of the left or right hepatic artery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of "hepatocellular carcinoma(HCC)"; 2. Tumor is located in the left or right lobe of liver without macrovascular tumor embolus or extrahepatic metastasis; 3. Liver function is Child-Pugh A or B; 4. Patients that do not receive any other anti-tumor therapy previously.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of non-hepatocellular carcinoma by postoperative histopathology; 2. Patients that can not be followed-up regularly.

Design outcomes

Primary

Measure	Time frame
Postoperative recovery of liver function;	—

Secondary

Measure	Time frame
Intraoperative blood loss;	—

Countries

China

Contacts

Public ContactJing LI

li_5hao@163.com+86 021 81875503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026